Interestingly, CXCR4 has recently been identified to be part of a core Th signature, co-expressed with GM-CSF, that is associated with MS (207), which strongly implicates this receptor in pathogenic T cell homing. The gene discussed is CSF2; the disease is myeloid sarcoma.